Report No. 055 - Protection of the Thyroid Gland in the Event of Releases of Radioiodine

 
Product Details:
  Report No. 055 - Protection of the Thyroid Gland in the Event of Releases of Radioiodine
  Formats Available: hardcopy, electronic (downloadable PDF)
 
Price:   $ 20.00   hardcopy
    $ 16.00   PDF (20% discount off hardcopy)             
  * $ 34.00   hardcopy & PDF
    * Includes an additional 10% discount off the hardcopy price
Category:   Reports
  Qty of hardcopy
  Qty of PDF
 
Executive Summary:
This Report considers the feasibility of utilizing thyroid blocking agents, as an additional option, for protection of the public in case of off-site releases. NCRP does not take any position concerning the question of utilizing thyroid blocking agents in any given situation. Rather, the purpose of this Report is to define the efficacy of such agents and the contraindications for their use, and, hence, the potential for use of thyroid blocking agents. In view of concern about the possibility of large releases of radioiodine from nuclear reactors, the use of evacuation to mitigate the consequences of such a relew ia also discussed in this Report.
 
 
Excerpts:
Table of Contents
Preface
 
  Scientific Committee:
Eugene L. Saenger, Chairman

Eight expert members.

7910 Woodmont Avenue, Suite 400 | Bethesda, MD 20814-3095
Telephone: (301) 657-2652 | Fax: (301) 907-8768 | Email: NCRPpubs@NCRPonline.org
Executive Director, D.A. Schauer
Legal Notice | Copyright Notice